Evidence map›Paper›PMID 39426983›Full record

ArticleNature communications2024

IGF2BP1 phosphorylation in the disordered linkers regulates ribonucleoprotein condensate formation and RNA metabolism.

Harald Hornegger, Aleksandra S Anisimova, Adnan Muratovic, Benjamin Bourgeois, Elena Spinetti, Isabell Niedermoser, Roberto Covino, Tobias Madl, G Elif Karagöz

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Harald HorneggerMax Perutz Laboratories Vienna, Vienna BioCenter, Vienna, Austria.
Aleksandra S AnisimovaMax Perutz Laboratories Vienna, Vienna BioCenter, Vienna, Austria.
Adnan MuratovicMax Perutz Laboratories Vienna, Vienna BioCenter, Vienna, Austria.ORCID 0009-0007-7775-6171
Benjamin BourgeoisOtto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.
Elena SpinettiInstitute of Biophysics, Goethe University Frankfurt, Frankfurt am Main, Germany.ORCID 0009-0009-1831-7480
Isabell NiedermoserMax Perutz Laboratories Vienna, Vienna BioCenter, Vienna, Austria.ORCID 0000-0002-5301-3361
Roberto CovinoFrankfurt Institute for Advanced Studies, Frankfurt am Main, Germany.
Tobias MadlOtto Loewi Research Center, Medicinal Chemistry, Medical University of Graz, Graz, Austria.ORCID 0000-0002-9725-5231
G Elif KaragözMax Perutz Laboratories Vienna, Vienna BioCenter, Vienna, Austria. guelsuen.karagoez@meduniwien.ac.at.ORCID 0000-0002-3392-2250

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) FWF-SFB F79Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) FWF-W 1261Austrian Science Fund FWF I 3792
6 · The paper itself

Abstract

The insulin-like growth factor 2 mRNA binding protein 1 (IGF2BP1) is a conserved RNA-binding protein that regulates RNA stability, localization and translation. IGF2BP1 is part of various ribonucleoprotein (RNP) condensates. However, the mechanism that regulates its assembly into condensates remains unknown. By using proteomics, we demonstrate that phosphorylation of IGF2BP1 at S181 in a disordered linker is regulated in a stress-dependent manner. Phosphomimetic mutations in two disordered linkers, S181E and Y396E, modulate RNP condensate formation by IGF2BP1 without impacting its binding affinity for RNA. Intriguingly, the S181E mutant, which lies in linker 1, impairs IGF2BP1 condensate formation in vitro and in cells, whereas a Y396E mutant in the second linker increases condensate size and dynamics. Structural approaches show that the first linker binds RNAs nonspecifically through its RGG/RG motif, an interaction weakened in the S181E mutant. Notably, linker 2 interacts with IGF2BP1's folded domains and these interactions are partially impaired in the Y396E mutant. Importantly, the phosphomimetic mutants impact IGF2BP1's interaction with RNAs and remodel the transcriptome in cells. Our data reveal how phosphorylation modulates low-affinity interaction networks in disordered linkers to regulate RNP condensate formation and RNA metabolism.

Indexed as

RibonucleoproteinsRNARNA-Binding ProteinsHEK293 CellsHeLa CellsHumansMutationPhosphorylationProtein BindingIGF2BP1 protein, humanRibonucleoproteinsRNARNA-Binding Proteins

Identifiers

PMID39426983
PMCPMC11490574

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.